26th Nov 2020 12:48
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Brendan McAtamney | ||||
| ||||||
Reason for the notification
| ||||||
a) | Position/status | PDMR - Chief Executive - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc | ||||
b) | LEI |
549300IWG5ZPP6B8HH13 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Additional grant of nominal cost options under the 2019 Performance Share Plan in relation to the year to 30 September 2020.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction | 25/11/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 JANUARY 2025 to 4 DECEMBER 2026
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Nigel Clerkin | ||||
| ||||||
Reason for the notification
| ||||||
a) | Position/status | PDMR -Chief Financial Officer - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name |
UDG Healthcare plc | ||||
b) | LEI |
549300IWG5ZPP6B8HH13 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Additional grant of nominal cost options under the 2019 Performance Share Plan in relation to the year to 30 September 2020.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction |
25/11/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 JANUARY 2025 to 4 DECEMBER 2026
| ||||
For further information, please contact:
Damien Moynagh
General Counsel & Company Secretary
Tel: +353-1-4689000
Related Shares:
UDG.L